Health in Brazil 1,092 indicators covering health for Brazil. IndicatorLatest Year10-yr change Rank Medical doctors 49.3% 2024 up 15.2% 43rd Number of presumed malaria cases 0 2024 — 40th Contraceptive prevalence, any modern method 79.5% 2019 up 21.9% 1st Number of indigenous malaria cases 138,620 2024 down 1.8% 39th Number of confirmed malaria cases 163,622 2024 down 3.4% 39th Total number of malaria cases 163,622 2024 down 3.4% 39th Retreatment cases: treatment after default 3,204 2012 down 19.6% 3rd Yellow fever vaccine (YFV) immunization coverage among 1-year olds 72.0% 2025 up 56.5% 17th Number of indigenous P. falciparum malaria cases 24,655 2024 up 67.0% 48th Number of suspected malaria cases 1.53 million 2024 down 3.8% 38th Retreatment cases: other 4,133 2012 down 53.4% 10th Retreatment cases: treatment after failure 296 2012 up 218.3% 21st Number of malaria positive cases by microscopy 109,878 2024 down 21.4% 30th Number of malaria suspects examined by microscopy 1.33 million 2024 down 15.3% 17th Absolute number of deaths from ambient particulate air pollution 52,300 2015 up 11.5% 11th Natural disasters deaths 0 2025 — 7th Tuberculosis funding versus budget requirement 59.39 million 2025 up 23.8% 8th Preterm birth rate 11.15 2020 down 6.8% 14th Preterm birth 310,651 2020 down 14.6% 9th Percentage of people living with HIV who have suppressed viral loads 69 2025 up 21.1% 54th Percentage of people living with HIV receiving treatment who have 96 2025 up 5.5% 35th Antenatal care coverage - at least four visits 93.8% 2023 up 5.4% 24th Number of reported deaths from cholera 0 2011 — 51st Number of cases of cutaneous leishmaniasis reported 9,810 2024 down 52.0% 4th Domestic Expenditure on Malaria 102.97 million 2024 up 32.0% 4th Number of cases of visceral leishmaniasis reported 1,245 2024 down 63.9% 4th Laboratories providing tuberculosis diagnostic services using culture 7.9 2014 up 58.0% 48th Number of malaria positive cases by rapid diagnostic test 32,128 2024 up 868.3% 46th Laboratories providing tuberculosis diagnostic services using sputum 1.6 2014 down 23.8% 51st Congenital syphilis number of cases, reported 25,002 2023 up 82.4% 1st Number of malaria suspects examined by rapid diagnostic test 197,094 2024 up 1,068.7% 52nd Pregnant women receiving prenatal care of at least four visits 92.7% 2019 up 3.6% 4th Average cost of tuberculosis treatment multi drug resistant 4,102 2024 up 44.7% 10th Completeness of death registration with cause-of-death information 99.0% 2016 up 6.5% 49th Congenital syphilis rate per 100 000 live births, reported 985.77 2023 up 108.7% 1st Nursing personnel 86.2% 2024 up 0.8% 38th Health worker distribution, by sex and type of occupation 86.2% 2024 up 0.8% 37th Number of people who received treatment with antibiotics for trachoma 0 2025 down 100.0% 22nd Treatment success rate: XDR-TB cases 80 2022 up 220.0% 24th Participation rate in organized learning (one year before the) 97.5% 2016 up 10.6% 28th Antenatal care attendees positive for syphilis who received treatment 90.4% 2023 up 4.8% 50th Hpv vaccination coverage in 15 year olds 90 2024 down 8.2% 12th Population in areas that warrant treatment with antibiotics, facial 0 2025 down 100.0% 23rd Sales of beer in 1000s hectolitres 114.58 2009 up 40.0% 57th Confirmed cases of MDR-TB 684 2012 up 83.4% 13th Number of people operated for trachomatous trichiasis 11 2025 down 99.3% 32nd New cases: other 11 2012 — 21st Compliance with international health regulations 97 2016 up 83.0% 15th Number of malaria cases treated with any first line tx courses 163,049 2024 down 66.8% 36th Number of indigenous P. vivax malaria cases 111,495 2024 down 9.2% 7th Deaths and disappearances during migration 13 2024 up 225.0% 37th Number of imported malaria cases 3,386 2024 down 31.3% 7th Number of malaria cases treated with artemisinin-based combination 29,829 2024 down 59.9% 42nd Number of imported cases of cutaneous leishmaniasis reported 213 2021 — 2nd Number of people protected from malaria by indoor residual spraying 216,442 2024 down 21.7% 28th Number of imported cases of visceral leishmaniasis reported 3 2021 — 11th Primary health care expenditure (PHCE) per сapita in US$ 374.61 2022 up 10.0% 33rd Reported number of individuals treated for onchocerciasis 11,514 2024 up 16.8% 29th Proportion of bloodstream infection due to Escherichia coli resistant 34.4% 2023 up 116.2% 31st Proportion of bloodstream infection due to methicillin-resistant 27.5% 2023 up 147.7% 29th ← Previous Page 18 of 19 Next →